United States · FDA National Drug Code directory
Loteprednol Etabonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70244-034_4faa8338-1297-3876-e063-6294a90a42fa
- Product NDC
- 70244-034
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- Loteprednol Etabonate
- Labeler
- Sentiss Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260417
- Source listing expiry
- 20271231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (70244-034-01) / 5 mL in 1 BOTTLE, DROPPER · 70244-034-01
- 1 BOTTLE, DROPPER in 1 CARTON (70244-034-02) / 10 mL in 1 BOTTLE, DROPPER · 70244-034-02
- 1 BOTTLE, DROPPER in 1 CARTON (70244-034-03) / 15 mL in 1 BOTTLE, DROPPER · 70244-034-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →